Dynamic MR imaging of breast lesions: Correlation with microvessel distribution pattern and histologic characteristics of prognosis

Radiology

Volumn 239, Issue 2, 2006, Pages 351-360

  Teifke, Andrea ^a   Behr, Oliver ^a   Schmidt, Markus ^a   Victor, Anja ^a   Vomweg, Toni W ^a   Thelen, Manfred ^a   Lehr, Hans Anton ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; BREAST CARCINOMA; BREAST FIBROADENOMA; BREAST PAPILLOMA; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FIBROCYSTIC BREAST DISEASE; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; KRUSKAL WALLIS TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MASTECTOMY; MASTITIS; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RANK SUM TEST; REVIEW; SCAR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; MIDDLE AGED; PROGNOSIS;

EID: 33646136903     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2392050205     Document Type: Review

References (38)

1. Kulil CK, Schild HH. Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging 2000;12:965-974.
2. Nunes I.W, Schnall MD, Siegelman ES, et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR Am J Roentgenol 1997;169:409-415.
3. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
4. Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-761.
5. Hall NR, Fish DE, Hunt N, et al. Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1992;1:223-229.
6. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:110-1124.
7. Magno WB, Hirschfield L, Bhuiya T, Harrison G, Mir R. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival. Coun Med 1992;56:667-669.
8. Weidner N, Folkman J, Pozza F, et al. Tumor angiogonosis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
9. Haerslev T, Jacobsen GK. Proliferating cell nuclear antigen in breast carcinomas: an immunohistochemical study with correlation to histopathological features and prognostic factors. Virchows Arch 1994;424:39-46.
10. Belien JA, van Diest PJ, Baak JP. Relationships between vascularization and proliferation in invasive breast cancer. J Pathol 1999;189:309-318.
11. Mussurakis S, Buckley DL, Horsman A. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 1997;203:317-321.
12. Stomper PC, Winston JS, Herman S, et al. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 1997;45:39-46.
13. Bone B, Aspelin P, Bronge L, Veress B. Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 1998;39:279-284.
14. Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425-2435.
15. Heywang-Kobrunner SH, Bick U, Bradley WG Jr, et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 2001;11:531-546.
16. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer; experience from a large study with long-term follow-up. Histopathology 1991;19:403-410.
17. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classilication of breast ductal carcinoma-in-situ. Lancet 1995;345:1154-1157.
18. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 1997;45:1559-1565.
19. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-447.
20. Da Silva ID, De Lima GR, Gebrim LH, et al. Invasive ductal carcinoma, fibroadenoma and adjacent breast stroma angiogenesis: an immunohistochemical and morphometrical study. Bull Assoc Anat (Nancy) 1996;80:17-19.
21. Brein SS, Jensen HM, Gullino PM. Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 1978;41:239-244.
22. Weind KL, Maier CF, Rutt BK, Moussa M. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions- implications for imaging modalities. Radiology 1998;208:477-483.
23. Buadu LD, Murakami J, Murayama S, et al. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis. J Comput Assist Tornogr 1997;21:421-430.
24. Jitsuiki Y, Hasebe T, Tsuda H, et al. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast. Mod Pathol 1999;12:492-498.
25. Hasebe T, Mukai K, Tsuda H, et al. New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus. Pathol Int 2000;50:263-272.
26. Matsubayashi R, Matsuo Y, Edakimi G, et al. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000;217:841-848,
27. Kato T, Kimura T, Miyakawa R, et al. Clinicopathologic study of angiogenesis in Japanese patients with breast cancer. World J Surg 1997;21:49-56.
28. Fridman V, Humblet C, Bonjean K, Boniver J. Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis find pathological factors. Virchows Arch 2000;437:611-617.
29. Valkovic T, Dobrila F, Melato M, et al. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 2002;440:583-588.
30. Vermeulen PB, Fox SB, Dirix LY, Colpaert C, Van Marck HA. Heterogeneity of vascularisation in invasive breast carcinoma. Eur J Cancer 2002;38:1951-1952.
31. Frouge C, Guinebretiere JM, Contesso G, Di Paola R, Blery M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994;29:1043-1049.
32. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic: findings and tumor angiogenesis. Radiology 1996;200:639-649.
33. Buckley DL, Drew PJ, Mussurakis S, Monson JR, Horsman A. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 1997;7:401-404.
34. Esserman L, Hylton N, George T, Weidner N. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 1999;5:13-21.
35. Hulka CA, Edmister WB, Smith BL, et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997;205:837-842.
36. Su MY, Cheung YC, Fruehauf JP, et al. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging 2003;18:467-477.
37. Mussurakis S, Buckley DL, Horsman A. Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br J Radiol 1997;70:446-451.
38. Stomper PC, Herman S, Klippenstein DL, et al. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. Cancer 1996;77:1844-1849.